Silvia S Barbieri Selected Research

Silvia S Barbieri Research Topics

Disease

12	Thrombosis (Thrombus) 03/2022 - 01/2006
3	Myocardial Infarction 02/2022 - 09/2012
2	Thromboembolism 03/2022 - 11/2015
2	Obesity 12/2020 - 08/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 03/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017 - 01/2016
2	Atherosclerosis 03/2013 - 01/2006
2	Inflammation (Inflammations) 06/2007 - 07/2004
1	ST Elevation Myocardial Infarction 07/2021
1	Overweight 12/2020
1	Mental Disorders (Mental Disorder) 10/2020
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Carotid Artery Thrombosis 05/2017
1	Venous Thromboembolism 01/2016
1	Stroke (Strokes) 03/2013
1	Necrosis 06/2011
1	Wounds and Injuries (Trauma) 05/2009
1	Fibrosis (Cirrhosis) 03/2009
1	Vascular Remodeling 06/2007
1	Hyperlipoproteinemias 01/2006
1	Carotid Artery Diseases 01/2006

Drug/Important Bio-Agent (IBA)

7	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2022 - 01/2017
3	CollagenIBA 03/2022 - 09/2012
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017 - 09/2012
3	Thromboplastin (Tissue Factor)IBA 01/2016 - 09/2012
2	Fibrinogen (Factor I)FDA Link 03/2022 - 01/2017
2	Epinephrine (Adrenaline)FDA LinkGeneric 03/2022 - 05/2017
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 11/2020
2	Sirtuin 1IBA 05/2017 - 09/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 05/2009
2	acetovanillone (apocynin)IBA 01/2017 - 07/2004
2	ProstaglandinsIBA 01/2017 - 09/2015
2	ThromboxanesIBA 01/2016 - 03/2013
2	SmokeIBA 09/2015 - 06/2007
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 03/2013 - 09/2012
1	prenylcysteineIBA 03/2022
1	Oxidoreductases (Dehydrogenase)IBA 03/2022
1	Desipramine (Pertofrane)FDA LinkGeneric 02/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2022
1	TroponinIBA 07/2021
1	Fibronectins (Fibronectin)IBA 07/2021
1	cadherin 5IBA 07/2021
1	Prealbumin (Transthyretin)IBA 07/2021
1	Ceruloplasmin (Ferroxidase)IBA 07/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2021
1	LeptinIBA 12/2020
1	KynurenineIBA 10/2020
1	FibrinIBA 01/2019
1	ResveratrolIBA 05/2017
1	CAY10591IBA 05/2017
1	Plasminogen Activator Inhibitor 1IBA 01/2017
1	carboprostacyclinIBA 01/2017
1	Annexin A2 (Annexin II)IBA 01/2017
1	Factor VIII (Coagulation Factor VIII)IBA 01/2017
1	Malondialdehyde (Propanedial)IBA 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	Thromboxane B2IBA 01/2016
1	Prostaglandins EIBA 09/2015
1	Dinoprostone (PGE2)FDA Link 09/2015
1	LipoxygenasesIBA 03/2013
1	EicosanoidsIBA 03/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2012
1	Epoprostenol ReceptorsIBA 09/2012
1	ferric chlorideIBA 09/2012
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2012
1	Thrombin FDA Link 09/2012
1	Proteins (Proteins, Gene)FDA Link 06/2011
1	Messenger RNA (mRNA)IBA 06/2011
1	Interleukin-1beta (Interleukin 1 beta)IBA 06/2011
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2009
1	beta CateninIBA 06/2007
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2006
1	LipidsIBA 01/2006
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2006
1	Pharmaceutical PreparationsIBA 01/2006

Therapy/Procedure

2	Ligation 01/2017 - 01/2016
1	Splenectomy 11/2015
1	Therapeutics 03/2009